COMMUNIQUÉS West-GlobeNewswire

GENFIT : Résultats financiers 2018 : Trésorerie de clôture de 207.2m€ au 31.12.2018
05/02/2019
GENFIT : Résultats financiers 2018 : Trésorerie de clôture de 207.2m€ au 31.12.2018 Étapes décisives franchies par GENFIT en 2018 : achèvement du recrutement de la cohorte d'analyse intermédiaire de l'essai de phase 3 [...]
Veritas Pharma to Proceed with Share Consolidation
05/02/2019
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) announces that it is proceeding with a consolidation of its [...]
The Ensign Group Schedules Year-End 2018 Earnings Call for Thursday, February 7, 2019
05/02/2019
MISSION VIEJO, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, assisted living, home health, [...]
REVA Announces Reduction in Force
05/02/2019
SAN DIEGO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced it is realigning the organization [...]
PRA Health Sciences to Report Fourth Quarter 2018 Earnings
04/02/2019
RALEIGH, N.C., Feb. 04, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and year end 2018 results after the market closes on Wednesday, February 27, 2019. The Company [...]
Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388
04/02/2019
IL-27 is a key regulator of checkpoint protein expression SRF388 believed to be the only anti-IL-27 targeted agent in late-preclinical development Investigational New Drug (IND) submission for SRF388 expected in Q4 2019 [...]
OPKO Health, Inc. Announces Proposed Offering of Convertible Senior Notes
04/02/2019
MIAMI, Feb. 04, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (“OPKO Health” or the “Company”) (NASDAQ: OPK) today announced that, subject to market and other conditions, it intends to offer $200 million aggregate [...]
Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14
04/02/2019
DUBLIN, Ireland, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, announced today that it will report its fourth quarter and full year 2018 financial [...]
Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck
04/02/2019
REDWOOD CITY, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the signing of a new agreement with Merck, through a subsidiary. Under the terms of [...]
DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019
04/02/2019
Montrouge, France, February 4, 2019 DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019 Novel immunotherapy based on Viaskin technology highlighted as a potential treatment for food-allergic [...]
DBV Technologies présentera des données sur l'immunothérapie épicutanée au congrès de l'AAAAI 2019
04/02/2019
Montrouge, France, le 4 février (22 :00 CET) 2019 DBV Technologies présentera des données sur l'immunothérapie épicutanée au congrès de l'AAAAI 2019 L'immunothérapie innovante de DBV, reposant sur la technologie Viaskin [...]
VIVUS Announces Date of 2019 Annual Meeting
04/02/2019
CAMPBELL, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that the Company will hold its 2019 Annual Meeting of Stockholders (the “2019 [...]
Generex Biotechnology Responds to Demand for Payment
04/02/2019
- Challenges notice from Alpha Capital MIRAMAR, FL, Feb. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote [...]
bioAffinity Technologies Announces Award of Canadian Patent
04/02/2019
SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies , a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the Company’s claims [...]
Cannabis Retailers: The Dawn of a New Industry
04/02/2019
VANCOUVER, British Columbia, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Mugglehead believes that Canadian cannabis retailers will be the next big focus for the industry. The current marijuana retail industry is practically non- [...]
Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer
04/02/2019
Kiadis Pharma appoints Dr. Robert Friesen as Chief Scientific Officer Amsterdam, The Netherlands, and Boston, Massachusetts, USA - February 4, 2019 - Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam [...]
New Hampshire Proposes Involuntary Servitude for Medical Professionals, States Association of American Physicians and Surgeons
04/02/2019
TUCSON, Ariz., Feb. 04, 2019 (GLOBE NEWSWIRE) -- New Hampshire has introduced legislation that essentially requires all licensed and actively practicing “health care practitioners and facilities” to accept as many [...]
New York Legalizes, Celebrates Defining Full-Term, Unborn Babies as Nonpersons, States Association of American Physicians and Surgeons
04/02/2019
TUCSON, Ariz., Feb. 04, 2019 (GLOBE NEWSWIRE) -- New York’s recently passed Reproductive Health Act states: “’Person,’ when referring to the victim of a homicide, means a human being who has been born and is alive” [...]
Virginia Governor Contradicts Oath of Hippocrates, States Association of American Physicians and Surgeons
04/02/2019
TUCSON, Ariz., Feb. 04, 2019 (GLOBE NEWSWIRE) -- In supporting abortion up to the moment of birth and even after, Virginia Governor Ralph Northam, M.D., a pediatric neurologist, has clearly renounced the Oath of [...]

Pages